Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 4 Interventional Results available

A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission

ClinicalTrials.gov ID: NCT03281304

Public ClinicalTrials.gov record NCT03281304. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 10, 2026, 9:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 3B/4, MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PARALLEL GROUP STUDY OF TOFACITINIB (CP-690,550) IN SUBJECTS WITH ULCERATIVE COLITIS IN STABLE REMISSION

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is a follow up study for subjects with Ulcerative Colitis (UC) in stable remission designed to evaluate flexible dosing of CP-690,550.

Study identification

NCT ID
NCT03281304
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
140 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 15, 2017
Primary completion
Feb 13, 2020
Completion
Mar 17, 2022
Last update posted
Mar 20, 2023

2017 – 2022

United States locations

U.S. sites
24
U.S. states
11
U.S. cities
17
Facility City State ZIP Site status
Surgicare of Mobile Mobile Alabama 36606
Alabama Medical Group, P.C. Mobile Alabama 36608
Clinical Applications Laboratories, Inc. San Diego California 92103
Bristol Hospital Bristol Connecticut 06010
Connecticut Clinical Research Institute Bristol Connecticut 06010
Central Connecticut Endoscopy Center Plainville Connecticut 06062
Advanced Medical Research Center Port Orange Florida 32127
Florida Medical Clinic, P.A. Zephyrhills Florida 33542
Cotton-O'Neil Clinical Research Center, Digestive Health Topeka Kansas 66606
Chevy Chase Endoscopy Center Chevy Chase Maryland 20815
MGG Group Co., Inc., Chevy Chase Clinical Research Chevy Chase Maryland 20815
Clinical Research Institute of Michigan, LLC Chesterfield Michigan 48047
Eastside Endoscopy Center Macomb Michigan 48044
Clinical Research Institute of Michigan, LLC Troy Michigan 48098
NYU Langone Long Island Clinical Research Associates Lake Success New York 11042
Columbia University Irving Medical Center New York New York 10032
Columbia University Medical Center Research Pharmacy/ Milstein Hospital New York New York 10032
Great Lakes Gastroenterology Research, LLC Mentor Ohio 44060
Memorial Hermann Hospital Houston Texas 77030
The University of Texas Health Science Center at Houston (UTHealth)- McGovern Medical School Houston Texas 77030
Christus Trinity Mother Frances Endoscopy Center Tyler Texas 75701
Tyler Research Institute, LLC Tyler Texas 75701
Alpine Medical Group Salt Lake City Utah 84102
Wasatch Clinical Research, LLC Salt Lake City Utah 84107

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 56 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03281304, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 20, 2023 · Synced Sep 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03281304 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →